Scilex Holding Co

Scilex Holding Company emerged from a business combination with Vickers Vantage Corp. I (Nasdaq: VCKA), a blank-check company sponsored by Vickers Capital Group that completed its initial public offering in 2021. The SPAC targeted the healthcare and life sciences sector, and its merger with Scilex Pharmaceuticals, a specialty pharmaceutical company focused on non-opioid pain management products, produced the current operating entity. Scilex Holding filed an 8-K with the Securities and Exchange Commission on June 23, 2025, providing a material disclosure to investors. To access full filing histories, sponsor profiles, and real-time SPAC analytics, sign up for complete data on SpacDesk.